Outsmarting Cancer to Deliver More Cures
CARGO is developing next-generation transformational CAR T-cell therapies with the mission of outsmarting cancer to deliver more cures for patients.
News
CARGO Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Read More ⟶: "https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-present-42nd-annual-jp-morgan-healthcare"CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results
Read More ⟶: "https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-reports-business-updates-and-third-quarter"CARGO Therapeutics Announces Scientific Advisory Board
Read More ⟶: "https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-announces-scientific-advisory-board"
Life at CARGO
CARGO Therapeutics is Now Hiring. Join us to make a difference.
Open Positions ⟶